Skip to main content
Veterinary Medicines

PANACUR 2,5 % SUSPENSION BUVABLE POUR BOVINS OVINS ET CAPRINS

Authorised
  • Fenbendazole

Product identification

Medicine name:
PANACUR 2,5 % SUSPENSION BUVABLE POUR BOVINS OVINS ET CAPRINS
Active substance:
  • Fenbendazole
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        11
        day
      • Milk
        6
        day
    • Sheep
      • Meat and offal
        16
        day
      • Milk
        9
        hour
    • Goat
      • Meat and offal
        16
        day
      • Milk
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6213550 8/1985
Date of authorisation status change:

Documents

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 26/08/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."